reports
Xtract One Selected to Support School Safety Across Granville County P...
Xtract One Selected to Support School Safety Across Granville County Public Schools Gateway’s AI-Powered Weapons Detection Systems Help Ensure Efficient Screening of Students and Staff TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its (“Gateway”) system has been selected by in Oxford, North Carolina to strengthen security while minimizing ingress delays and reducing the need for manual bag checks. The initial deployment will take place at two of the district’s high schools and support Granville County P...
- Teresa Ortiz
CBH Engineering Holding Berhad: 1 director
A director at CBH Engineering Holding Berhad sold 75,800,000 shares at 0.600MYR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Gamuda Berhad: 2 directors
Two Directors at Gamuda Berhad sold 90,000 shares at between 4.430MYR and 4.445MYR. The significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Frontken Corporation Berhad: 1 director
A director at Frontken Corporation Berhad sold 29,177,800 shares at 0.000MYR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Tanco Holdings Berhad: 1 director
A director at Tanco Holdings Berhad bought 7,706,000 shares at 1.602MYR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Aebi Schmidt Group to announce first quarter 2026 earnings on May 14, ...
Aebi Schmidt Group to announce first quarter 2026 earnings on May 14, 2026 FRAUENFELD, Switzerland, April 30, 2026 (GLOBE NEWSWIRE) -- Aebi Schmidt Holding AG (NASDAQ: AEBI) (“Aebi Schmidt Group” or the “Company”), a world-class specialty vehicles leader, will announce its first quarter 2026 earnings before the market opens on Thursday, May 14, 2026, and host an earnings conference call and webcast at 8:30am Eastern Time the same day. Investors and analysts can access the conference call and webcast, including conference call materials, at , or directly through: for the webcast, an...
Aptose Biosciences Announces Update on Anticipated Timing of Closing o...
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical SAN DIEGO and TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) announced today that closing of the previously announced arrangement (the “Arrangement”) with Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North America Ltd., a wholly owned subsidiary of Hanmi (“Hanmi Purchaser” and together with Hanmi, the “Hanmi Purchasers”), has been delayed as certain Korean regulatory approvals pertaining to the A...
DT Midstream Reports Strong First Quarter 2026 Results
DT Midstream Reports Strong First Quarter 2026 Results DETROIT, April 30, 2026 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced first quarter 2026 reported net income of $130 million, or $1.27 per diluted share. For the first quarter of 2026, Operating Earnings were $130 million, or $1.27 per diluted share. Adjusted EBITDA for the quarter was $308 million. Reconciliations of Operating Earnings and Adjusted EBITDA (non-GAAP measures) to reported net income are included at the end of this news release. The company also announced that the DT Midstream Board of Director...
BridgeBio to Report First Quarter 2026 Financial Results and Commercia...
BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET PALO ALTO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its first quarter 2026 financial results and business update after the market closes on Thursday, May 7, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day. To access ...
SIGA to Host Business Update Call on May 7, 2026, Following Release of...
SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 7, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Inv...
Helus Pharma to Participate at the 29th Annual Milken Institute Global...
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference Eric So, Interim CEO, to appear on panel entitled “The Next Wave of Health Innovation,” on May 4, 2026 NEW YORK and TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Eric So, Helus Pharma’s Interim Chief Executive Officer, will be speaking at the 29th Annual Milken Institute Global Conference on a panel entitled “The Next Wav...
Parex Resources Announces Preliminary First Quarter Results
Parex Resources Announces Preliminary First Quarter Results CALGARY, Alberta, April 30, 2026 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce select, preliminary results for the three-month period ended March 31, 2026, based on information currently available to Management. The Company is providing this information to ensure fair and transparent disclosure to all parties ahead of a proposed debt financing in connection with its acquisition of Frontera Energy’s Colombian E&P assets (the “Frontera Transaction”), as previously announced on...
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCY...
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, and led by Professor Paolo A. Ascierto of the Istituto Nazionale Tumori Fondazione “G. Pascale”, a leading cancer centre in Europe TORONTO and HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and...
Parker Reports Fiscal 2026 Third Quarter Results
Parker Reports Fiscal 2026 Third Quarter Results Record Sales of $5.5 Billion Drive Record Cash Flow and Adjusted EPS; Orders +9% CLEVELAND, April 30, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended March 31, 2026, that included the following highlights (compared with the prior year period): Fiscal 2026 Third Quarter Highlights: Sales increased 11% to a record $5.5 billion; organic sales increased 6.5%Segment operating margin was 23.4%, an increase of 20 bps, or 26.7% ad...
Roadzen Secures LOI for $30 Million Insurance Capacity Commitment From...
Roadzen Secures LOI for $30 Million Insurance Capacity Commitment From Leading U.S. Carrier to Bring AI to Commercial Auto Insurance, Backed by Over $50 Million in Producer Demand Capacity expected to scale to $50 million over three years; program anticipated to contribute approximately $6 million in revenue in Year 1, scaling alongside capacity Roadzen's U.S. producer and agency network has more than $50 million in committed premium demand for the program NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the convergence of insurance and...
Dragonfly Energy to Report First Quarter 2026 Financial and Operationa...
Dragonfly Energy to Report First Quarter 2026 Financial and Operational Results on May 14, 2026 RENO, Nev., April 30, 2026 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, today announced that the Company will release its financial and operational results for the first quarter ended March 31, 2026 after market close on Thursday, May 14, 2026. The earnings press release will be followed by a conference call on Thursday, May 14, 2026, at 4:30 PM Eastern Time. I...
TG Therapeutics to Host Conference Call on First Quarter 2026 Financia...
TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update Conference Call to be Held Wednesday, May 6, 2026, at 8:30 am ET NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Wednesday, May 6, 2026, at 8:30 AM ET to discuss results for the first quarter 2026 and to provide a business outlook for the remainder of 2026. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-...
Yuanbao Inc. Files its Annual Report on Form 20-F for Fiscal Year 2025
Yuanbao Inc. Files its Annual Report on Form 20-F for Fiscal Year 2025 BEIJING, April 30, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on April 30, 2026. The annual report can be accessed on the Company’s investor relations website at . The Company will provide a hard copy of its annual report containing the audited consolidate...
CCC Intelligent Solutions Announces Chief Financial Officer Transition
CCC Intelligent Solutions Announces Chief Financial Officer Transition Rodney Christo Named Interim CFO and Chief Accounting Officer CHICAGO, April 30, 2026 (GLOBE NEWSWIRE) -- CCC Intelligent Solutions Holdings Inc. (CCC) (NASDAQ: CCC), a leading SaaS and AI platform provider for the multi-trillion-dollar insurance economy, today announced that Brian Herb, Executive Vice President, Chief Financial & Administrative Officer, will depart the Company effective May 25, 2026, to accept another opportunity. Effective upon Mr. Herb’s departure, Rodney Christo, currently CCC’s Senior Vice Pres...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.